Investiere

Total investments

116

Average round size

3M

Portfolio companies

83

Rounds per year

10.55

Lead investments

21

Follow on index

0.28

Exits

5

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyMobileHealth CareSaaSRoboticsManufacturingMedical DeviceMedical

Investments analytics

Analytics

Total investments
116
Lead investments
21
Exits
5
Rounds per year
10.55
Follow on index
0.28
Investments by industry
  • Software (24)
  • Medical (19)
  • Health Care (17)
  • Medical Device (16)
  • Information Technology (16)
  • Show 148 more
Investments by region
  • Switzerland (102)
  • France (2)
  • Belgium (1)
  • Austria (3)
  • United Kingdom (2)
  • Show 3 more
Peak activity year
2020

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
8
Avg. valuation at time of investment
475K
Group Appearance index
1.00
Avg. company exit year
6
Avg. multiplicator
1.24

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Haelixa 09 Sep 2019 Information Technology, Quality Assurance Seed Switzerland, Zurich, Zurich
Inveert 16 Mar 2022 Financial Services, FinTech, Finance, Virtual Assistant Seed 1M Andalucia, Seville, Spain
KiWi 17 Jan 2019 Financial Services, Finance Early Stage Venture 3M Switzerland, Vaud, Lausanne
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.